These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15073239)

  • 1. 186Re and high-specific-activity 177Lu available in North America.
    J Nucl Med; 2004 Apr; 45(4):22N. PubMed ID: 15073239
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones.
    Uehara T; Jin ZL; Ogawa K; Akizawa H; Hashimoto K; Nakayama M; Arano Y
    Nucl Med Biol; 2007 Jan; 34(1):79-87. PubMed ID: 17210464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.
    Michel RB; Andrews PM; Rosario AV; Goldenberg DM; Mattes MJ
    Nucl Med Biol; 2005 Apr; 32(3):269-78. PubMed ID: 15820762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications.
    Banerjee S; Pillai MR; Knapp FF
    Chem Rev; 2015 Apr; 115(8):2934-74. PubMed ID: 25865818
    [No Abstract]   [Full Text] [Related]  

  • 5. Rhenium-188--a generator-derived radioisotope for cancer therapy.
    Knapp FF
    Cancer Biother Radiopharm; 1998 Oct; 13(5):337-49. PubMed ID: 10851424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological dosimetry after radiosynoviorthesis with rhenium-186 sulphide and erbium-169 citrate.
    Klett R; Schnurbus-Duhs A; Mödder G; Schmid E; Voth M
    Nuklearmedizin; 2012; 51(1):17-25. PubMed ID: 21931934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals.
    Ogawa K; Mukai T; Arano Y; Ono M; Hanaoka H; Ishino S; Hashimoto K; Nishimura H; Saji H
    Bioconjug Chem; 2005; 16(4):751-7. PubMed ID: 16029015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
    Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors.
    Chen J; Linder KE; Cagnolini A; Metcalfe E; Raju N; Tweedle MF; Swenson RE
    Appl Radiat Isot; 2008 Apr; 66(4):497-505. PubMed ID: 18178448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An estradiol-conjugate for radiolabelling with 177Lu: an attempt to prepare a radiotherapeutic agent.
    Banerjee S; Das T; Chakraborty S; Samuel G; Korde A; Venkatesh M; Pillai MR
    Bioorg Med Chem; 2005 Jul; 13(13):4315-22. PubMed ID: 15927837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients.
    Derrey S; Blond S; Reyns N; Touzet G; Carpentier P; Gauthier H; Dhellemmes P
    Neurosurgery; 2008 Dec; 63(6):1045-52; discussion 1052-3. PubMed ID: 19057317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target burn-up corrected specific activity of 177Lu produced via 176Lu(n, gamma) 177Lu nuclear reactions.
    Zhernosekov KP; Perego RC; Dvorakova Z; Henkelmann R; Türler A
    Appl Radiat Isot; 2008 Sep; 66(9):1218-20. PubMed ID: 18359234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production logistics of 177Lu for radionuclide therapy.
    Pillai MR; Chakraborty S; Das T; Venkatesh M; Ramamoorthy N
    Appl Radiat Isot; 2003; 59(2-3):109-18. PubMed ID: 12941498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Lutetium-177 tin colloid and Rhenium-188 tin colloid radiosynovectomy in chronic knee arthritis.
    Shamim SA; Arora G; Jha P; Gupta P; Behera A; Mukherjee A; Prabhu M; Ansari MT; Vyas S; Bal C
    Nucl Med Commun; 2020 Aug; 41(8):721-726. PubMed ID: 32404646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhenium-188 and copper-67 radiopharmaceuticals for the treatment of bladder cancer.
    Frier M
    Mini Rev Med Chem; 2004 Jan; 4(1):61-8. PubMed ID: 14754444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of [186Re]rhenium(V)dimercaptosuccinic acid: a possible tumour radiotherapy agent.
    Bisunadan MM; Blower PJ; Clarke SE; Singh J; Went MJ
    Int J Rad Appl Instrum A; 1991; 42(2):167-71. PubMed ID: 1648035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals.
    Ferro-Flores G; Arteaga de Murphy C
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1389-401. PubMed ID: 18547675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis.
    Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
    Appl Radiat Isot; 2008 Sep; 66(9):1196-205. PubMed ID: 18372188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Lutetium-177 Labeled Therapeutics: Emerging Importance for Cancer Treatment and Therapy of Chronic Disease.
    Knapp FF; Pillai AM
    Curr Radiopharm; 2015; 8(2):77. PubMed ID: 25771381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.